ATE297947T1 - Cyclische azapeptide mit angiogener wirkung - Google Patents

Cyclische azapeptide mit angiogener wirkung

Info

Publication number
ATE297947T1
ATE297947T1 AT98936395T AT98936395T ATE297947T1 AT E297947 T1 ATE297947 T1 AT E297947T1 AT 98936395 T AT98936395 T AT 98936395T AT 98936395 T AT98936395 T AT 98936395T AT E297947 T1 ATE297947 T1 AT E297947T1
Authority
AT
Austria
Prior art keywords
angiogenic action
azapeptides
cyclic
cyclic azapeptides
angiogenic
Prior art date
Application number
AT98936395T
Other languages
German (de)
English (en)
Inventor
Alfred Jonczyk
Simon Goodman
Horst Kessler
Jochen Wermuth
Joerg Schmitt
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of ATE297947T1 publication Critical patent/ATE297947T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT98936395T 1997-07-04 1998-06-29 Cyclische azapeptide mit angiogener wirkung ATE297947T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19728524A DE19728524A1 (de) 1997-07-04 1997-07-04 Cyclische Azapeptide
PCT/EP1998/003955 WO1999001472A1 (de) 1997-07-04 1998-06-29 Cyclische azapeptide mit angiogener wirkung

Publications (1)

Publication Number Publication Date
ATE297947T1 true ATE297947T1 (de) 2005-07-15

Family

ID=7834596

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98936395T ATE297947T1 (de) 1997-07-04 1998-06-29 Cyclische azapeptide mit angiogener wirkung

Country Status (20)

Country Link
US (1) US6534478B1 (xx)
EP (1) EP1001979B1 (xx)
JP (1) JP2002511872A (xx)
KR (1) KR20010014267A (xx)
CN (1) CN1261895A (xx)
AR (1) AR010924A1 (xx)
AT (1) ATE297947T1 (xx)
AU (1) AU733831B2 (xx)
BR (1) BR9810394A (xx)
CA (1) CA2297181A1 (xx)
DE (2) DE19728524A1 (xx)
HU (1) HUP0003357A3 (xx)
ID (1) ID23415A (xx)
NO (1) NO20000016L (xx)
PL (1) PL337616A1 (xx)
RU (1) RU2188205C2 (xx)
SK (1) SK173599A3 (xx)
TW (1) TW482768B (xx)
WO (1) WO1999001472A1 (xx)
ZA (1) ZA985896B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA71608C2 (en) * 1999-03-11 2004-12-15 Merck Patent Gmbh A method for producing the cyclic pentapeptide
DE60027718T2 (de) * 1999-06-22 2007-05-16 Takeda Pharmaceutical Co. Ltd. Acylhydrazinderivate, verfahren zu ihrer herstellung und ihre verwendung
GB0217017D0 (en) * 2002-07-23 2002-08-28 Bioacta Ltd Peptide 2
WO2008033557A2 (en) * 2006-09-15 2008-03-20 Siemens Medical Solutions Usa, Inc. Click chemistry-derived cyclic peptidomimetics as integrin markers
US8043601B2 (en) * 2007-07-27 2011-10-25 Siemens Medical Solutions Usa, Inc. Cyclic azapeptides as integrin markers
WO2009134382A2 (en) * 2008-04-30 2009-11-05 Siemens Medical Solutions Usa, Inc. Cyclopeptides containing rgd mimetics as imaging markers for integrins
EP2288388B1 (en) * 2008-05-30 2016-08-31 Siemens Medical Solutions USA, Inc. Achievement of high therapeutic index through molecular imaging guided targeted drug treatment
CA2665302A1 (en) * 2009-05-01 2010-11-01 Universite De Montreal Cd36 modulation and uses thereof
CN101906144B (zh) * 2009-06-03 2013-06-19 首都医科大学 一根Arg-Gly-Asp-Val链通过Asp与两根脂肪醇链的偶联物、它们的合成及在医学中的应用
KR101335203B1 (ko) * 2010-03-26 2013-11-29 숙명여자대학교산학협력단 혈관신생촉진용 펩타이드 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2137072C (en) 1992-06-04 2000-06-13 Scott L. Harbeson Conformationally restrained peptide analogs as antiplatelet agents
UA43823C2 (uk) * 1992-07-06 2002-01-15 Мерк Патент Геселлшафт Міт Бесшренктер Хафтунг ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ДЛЯ ІНГІБУВАННЯ ІНТЕГРИН <font face="Symbol">a</font><sub>V</sub><font face="Symbol">b</font><sub>3</sub>-ОПОСЕРЕДКОВАНОЇ КЛІТИННОЇ АДГЕЗІЇ КЛІТИН ССАВЦІВ, СПОСІБ ЛІКУВАННЯ ТА ПРОФІЛАКТИКИ ЗАХВОРЮВАННЯ, АСОЦІЙОВАНОГО З ПОРУШЕННЯМ АДГЕЗІЇ КЛІТИН, СПОСІБ БЛОКУВАННЯ ЗВ'ЯЗУВАННЯ ФІБРИНОГЕНОМ ІНТЕГРИНУ, КОМПОЗИЦІЯ ДЛЯ ЗАГОЄННЯ РАН
AU1975695A (en) 1994-03-04 1995-09-18 Du Pont Merck Pharmaceutical Company, The Novel carbocyclic compounds which inhibit platelet aggregation by interaction with the gpiib/iiia receptor complex
US5858972A (en) 1996-01-11 1999-01-12 La Jolla Cancer Research Foundation Antithrombotic agents and methods of use
ZA978758B (en) * 1996-10-02 1999-03-30 Du Pont Merck Pharma Technetium-99m-labeled chelator incorporated cyclic peptides that bind to the GPIIb/IIIa receptor as imaging agents
DE19653036A1 (de) 1996-12-19 1998-06-25 Merck Patent Gmbh Cyclopeptidderivate

Also Published As

Publication number Publication date
CA2297181A1 (en) 1999-01-14
TW482768B (en) 2002-04-11
US6534478B1 (en) 2003-03-18
HUP0003357A3 (en) 2001-12-28
DE59812870D1 (de) 2005-07-21
PL337616A1 (en) 2000-08-28
KR20010014267A (ko) 2001-02-26
AU733831B2 (en) 2001-05-24
ID23415A (id) 2000-04-20
JP2002511872A (ja) 2002-04-16
ZA985896B (en) 1999-06-14
AR010924A1 (es) 2000-07-12
RU2188205C2 (ru) 2002-08-27
DE19728524A1 (de) 1999-01-07
WO1999001472A1 (de) 1999-01-14
EP1001979A1 (de) 2000-05-24
EP1001979B1 (de) 2005-06-15
AU8541198A (en) 1999-01-25
BR9810394A (pt) 2000-09-05
NO20000016D0 (no) 2000-01-03
SK173599A3 (en) 2000-06-12
NO20000016L (no) 2000-01-03
HUP0003357A2 (hu) 2001-02-28
CN1261895A (zh) 2000-08-02

Similar Documents

Publication Publication Date Title
DE29715364U1 (de) Waschzeug mit massierender Wirkung
DE69707099T2 (de) Nietartiges Befestigungselement
DE69820156D1 (de) VErbessertes monofilament
ATE290541T1 (de) Inositolglykane mit insulinartiger wirkung
BR9801683A (pt) Tecidos para entretela
DE69932218D1 (de) Von Magnetkraft Gebrauch machende Kammstruktur
ID24203A (id) Pestisidal 1-aril-3-iminopirazol
NO973273D0 (no) Sammenkoblingselement
ATE297947T1 (de) Cyclische azapeptide mit angiogener wirkung
DE69634543D1 (de) Thiol-derivative mit metallopeptidase hemmender wirkung
FR2768938B1 (fr) Raquette a neige
DE69412926T2 (de) Pultrudiertes elektrisches Kontakt-Hohlelement
DE69802700D1 (de) Waessrige konservierungsmittel
FR2760375B1 (fr) Raquette a neige
DE59812905D1 (de) Cyclische Polyaminsalze
DE69834529D1 (de) Ablenkendes element
DE69810575D1 (de) Elektrolumineszentes Element
DE59805449D1 (de) Verdrängerpumpe
ATE240297T1 (de) Substituierte phenylamidine mit antithrombotischer wirkung
DE69835157D1 (de) Reihenelektroden-anodisierung
DE29704161U1 (de) Kontaktelement
FR2747582B3 (fr) Raquette a neige
KR970053158U (ko) 곤충채집기
DE19726486B4 (de) Schaltelement
ID20763A (id) Mesin tenun

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee